RESQ Enhanced RESolution Quantum sensing for metabolic brain imaging
- Coordinator
- Nvision Quantum Technologies GmbH, Germany
- Runs
- 1 May 2026 to 30 April 2029
- Status
- Running
- EU funding
- €2.6m
- Total cost
- €2.6m
- Partners
- 5 organisations in 3 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101297341
What the project is doing
In the project's own words, from its summary on CORDIS.
Quantum sensing is starting to become a reality in a number of industries, yet its potential in medicine remains largely unrealised. Clinical use demands exceptional precision and robustness, which current technologies cannot provide. Hyperpolarised MRI (HP-MRI) could change this by enabling quantum-enhanced metabolic imaging, e. g. for the reliable detection of small brain metastases. Brain metastases occur in 10-20% of cancer patients with fewer than 5% living beyond three years after diagnosis.
Earlier detection could shift patients into more effective treatment pathways and significantly improve outcomes, yet small lesions often remain invisible with today’s imaging. RESQ will overcome this barrier by developing resolution-enhanced HP-MRI as an application-specific quantum sensing to meet the demands of brain imaging. RESQ unites complementary strengths and establishes a long-lasting partnership between NVision Imaging Technologies, a German SME leading innovation in hyperpolarisation; Yonsei öUniversity, the Republic of Korea's leading research centre in HP-MRI; Ulm University with deep expertise in advanced quantum control and Tesla Dynamic Coils (Netherlands), an industry leader in MR coils.
Together, we will (i) optimise parahydrogen generation and storage for reproducible high spin order; (ii) design quantum-optimised acquisition and reconstruction, integrating tailored RF pulses, compressed sensing, and machine learning and (iii) build dedicated dual-tuned brain coils. We will create the first EU-ROK quantum imaging node supporting researcher exchanges, joint training, sustainable infrastructure and contributions to international HP-MRI standards.
By bridging today’s resolution-limited HP-MRI to disease-focused quantum sensing, RESQ strengthens the European quantum ecosystem, anchors long-term EU-ROK collaboration and lays the foundation for clinical translation.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Nvision Quantum Technologies GmbH | Ulm | Germany | Coordinator |
| Universitaet Ulm | Ulm | Germany | Participant |
| University Industry Foundation Yonsei University | Seoul | South Korea | Third party |
| Yonsei University | Seoul | South Korea | Participant |
| Tesla Dynamic Coils BV | Zaltbommel | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI